Observational studyThe American journal of clinical nutrition2026
Nutritional anemia is associated with increased risk of severe COPD exacerbations: a prospective cohort study.
Observational study in The American journal of clinical nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAnemia prevalence in chronic obstructive pulmonary disease (COPD) varies widely across studies, and data on anemia subtypes and their association with mortality or COPD exacerbation readmission are limited.
objectivesWe aimed to investigate anemia subtypes and their association with mortality and readmission for acute exacerbation of COPD (AECOPD) in patients hospitalized for AECOPD.
methodsIn this prospective observational cohort study, patients with COPD aged ≥45 y hospitalized for severe exacerbations in a Belgian nationwide database were included. Cox regression models investigated associations between anemia (or its subtypes) and (postdischarge) mortality and AECOPD readmission, adjusted for age, sex, socioeconomic status, smoking, weight, and age-adjusted Charlson Comorbidity Index. Inverse probability of treatment weighting examined the association between anemia treatment and mortality across anemia subtypes.
resultsAmong 32,152 patients with COPD discharged from the hospital, 5956 (18.5%) had anemia. Nutritional anemia was most frequent (49.3%), followed by anemia of chronic disease (ACD; 31.3%). Anemia was associated with a 30% higher postdischarge mortality risk [adjusted hazard ratio (aHR): 1.30, 95% confidence interval (CI): 1.23, 1.37], and 8% higher readmission risk (aHR:1.08, 95% CI: 1.03, 1.14). Patients with hematologic anemia had the highest postdischarge mortality risk (aHR: 1.75, 95% CI: 1.54, 1.99), followed by nutritional anemia (aHR: 1.29, 95% CI: 1.20, 1.39). Only nutritional anemia was associated with increased readmission risk (aHR: 1.18, 95% CI: 1.10, 1.25). Treatment effects differed by anemia subtype, with iron, vitamin B12, and erythroid-stimulating agent (ESA) associated with lower postdischarge mortality in nutritional anemia; folic acid and iron in hematologic anemia; and ESA and iron in ACD.
conclusionsNutritional anemia is the predominant subtype in hospitalized patients with AECOPD, and its increased readmission risk calls closer attention to iron deficiency in patients with COPD. All subtypes of anemia are associated with higher postdischarge mortality risk, but targeted treatment may reduce mortality risk and represents a potential strategy to improve outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.